MitoRx Therapeutics
Harwell
About MitoRx Therapeutics
MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Funding stage: Seed
- Last round: Seed (Nov 2024)
- Website: mitorxtherapeutics.com
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/mitorx-therapeutics-57277 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.